bioMérieux Vergangene Ertragsentwicklung
Vergangenheit Kriterienprüfungen 4/6
bioMérieux verzeichnete einen durchschnittlichen jährlichen Gewinnzuwachs von 6.3%, während die Gewinne der Branche Medical Equipment jährlich um gewachsen und zwar um 14.5%. Die Umsätze verzeichneten einen durchschnittlichen jährlichen Gewinnzuwachs von gewachsen von 7.8%. Die Eigenkapitalrendite von bioMérieux beträgt 10.3% und die Nettomargen betragen 10.8%.
Wichtige Informationen
6.3%
Wachstumsrate der Gewinne
6.4%
EPS-Wachstumsrate
| Medical Equipment Wachstum der Industrie | 21.6% |
| Wachstumsrate der Einnahmen | 7.8% |
| Eigenkapitalrendite | 10.3% |
| Netto-Marge | 10.8% |
| Letzte Ertragsaktualisierung | 30 Jun 2024 |
Jüngste Aktualisierungen vergangener Leistungen
bioMérieux's (EPA:BIM) Conservative Accounting Might Explain Soft Earnings
Mar 31
There May Be Reason For Hope In bioMérieux's (EPA:BIM) Disappointing Earnings
Sep 15Recent updates
Is bioMérieux (EPA:BIM) Using Too Much Debt?
Nov 01Is There An Opportunity With bioMérieux S.A.'s (EPA:BIM) 31% Undervaluation?
Oct 14bioMérieux S.A.'s (EPA:BIM) Popularity With Investors Is Under Threat From Overpricing
Sep 26bioMérieux S.A. (EPA:BIM) Just Reported Interim Earnings: Have Analysts Changed Their Mind On The Stock?
Sep 08Return Trends At bioMérieux (EPA:BIM) Aren't Appealing
Aug 03bioMérieux S.A.'s (EPA:BIM) Price In Tune With Earnings
May 30Investors Met With Slowing Returns on Capital At bioMérieux (EPA:BIM)
Apr 18bioMérieux's (EPA:BIM) Conservative Accounting Might Explain Soft Earnings
Mar 31bioMérieux S.A. Just Missed Earnings - But Analysts Have Updated Their Models
Mar 17These 4 Measures Indicate That bioMérieux (EPA:BIM) Is Using Debt Reasonably Well
Mar 15bioMérieux S.A.'s (EPA:BIM) Price In Tune With Earnings
Jan 27bioMérieux (EPA:BIM) Has More To Do To Multiply In Value Going Forward
Jan 06A Look At The Intrinsic Value Of bioMérieux S.A. (EPA:BIM)
Dec 16These 4 Measures Indicate That bioMérieux (EPA:BIM) Is Using Debt Reasonably Well
Oct 23bioMérieux (EPA:BIM) Has Some Way To Go To Become A Multi-Bagger
Oct 05There May Be Reason For Hope In bioMérieux's (EPA:BIM) Disappointing Earnings
Sep 15Estimating The Intrinsic Value Of bioMérieux S.A. (EPA:BIM)
Sep 07Does bioMérieux (EPA:BIM) Have A Healthy Balance Sheet?
Jun 30Returns At bioMérieux (EPA:BIM) Appear To Be Weighed Down
Jun 09Is bioMérieux (EPA:BIM) Using Too Much Debt?
Mar 31The Return Trends At bioMérieux (EPA:BIM) Look Promising
Feb 23Do bioMérieux's (EPA:BIM) Earnings Warrant Your Attention?
Jan 27bioMérieux (EPA:BIM) Has A Pretty Healthy Balance Sheet
Dec 16bioMérieux (EPA:BIM) Ticks All The Boxes When It Comes To Earnings Growth
Oct 18Is bioMérieux (EPA:BIM) Using Too Much Debt?
Sep 14Investors Should Be Encouraged By bioMérieux's (EPA:BIM) Returns On Capital
Aug 11An Intrinsic Calculation For bioMérieux S.A. (EPA:BIM) Suggests It's 20% Undervalued
Jul 23Do bioMérieux's (EPA:BIM) Earnings Warrant Your Attention?
Jul 05bioMérieux's (EPA:BIM) Dividend Will Be Increased To €0.85
May 26Shareholders Would Enjoy A Repeat Of bioMérieux's (EPA:BIM) Recent Growth In Returns
May 11bioMérieux (EPA:BIM) Is Paying Out A Larger Dividend Than Last Year
Apr 23bioMérieux (EPA:BIM) Has Announced That It Will Be Increasing Its Dividend To €0.85
Apr 09bioMérieux's (EPA:BIM) Dividend Will Be Increased To €0.85
Mar 25Does bioMérieux (EPA:BIM) Have A Healthy Balance Sheet?
Mar 13I Ran A Stock Scan For Earnings Growth And bioMérieux (EPA:BIM) Passed With Ease
Feb 08Why We Like The Returns At bioMérieux (EPA:BIM)
Dec 21Calculating The Intrinsic Value Of bioMérieux S.A. (EPA:BIM)
Dec 07Here's Why We Think bioMérieux (EPA:BIM) Is Well Worth Watching
Nov 07Is bioMérieux (EPA:BIM) A Risky Investment?
Oct 07Investors Shouldn't Overlook bioMérieux's (EPA:BIM) Impressive Returns On Capital
Sep 22Estimating The Fair Value Of bioMérieux S.A. (EPA:BIM)
Sep 07Here's Why I Think bioMérieux (EPA:BIM) Might Deserve Your Attention Today
Aug 06There's Been No Shortage Of Growth Recently For bioMérieux's (EPA:BIM) Returns On Capital
Jun 15A Look At The Fair Value Of bioMérieux S.A. (EPA:BIM)
May 31Here's Why I Think bioMérieux (EPA:BIM) Might Deserve Your Attention Today
Apr 30bioMérieux (EPA:BIM) Could Easily Take On More Debt
Mar 28The Trend Of High Returns At bioMérieux (EPA:BIM) Has Us Very Interested
Mar 13Calculating The Intrinsic Value Of bioMérieux S.A. (EPA:BIM)
Feb 25If You Had Bought bioMérieux (EPA:BIM) Shares Five Years Ago You'd Have Earned 237% Returns
Feb 09If You Like EPS Growth Then Check Out bioMérieux (EPA:BIM) Before It's Too Late
Jan 20
Could The Market Be Wrong About bioMérieux S.A. (EPA:BIM) Given Its Attractive Financial Prospects?
Dec 30These 4 Measures Indicate That bioMérieux (EPA:BIM) Is Using Debt Reasonably Well
Dec 17Aufschlüsselung der Einnahmen und Ausgaben
Aufschlüsselung der Einnahmen und Ausgaben
Wie bioMérieux Geld verdient und ausgibt. Basierend auf den neuesten gemeldeten Einnahmen der letzten zwölf Monate.
Gewinn- und Umsatzhistorie
| Datum | Einnahmen | Umsatz | Allgemeine und Verwaltungskosten | F&E-Ausgaben |
|---|---|---|---|---|
| 30 Jun 24 | 3,807 | 411 | 1,055 | 474 |
| 31 Mar 24 | 3,741 | 384 | 1,038 | 467 |
| 31 Dec 23 | 3,675 | 358 | 1,021 | 460 |
| 30 Sep 23 | 3,688 | 372 | 1,019 | 463 |
| 30 Jun 23 | 3,701 | 386 | 1,017 | 466 |
| 31 Mar 23 | 3,645 | 419 | 986 | 456 |
| 31 Dec 22 | 3,589 | 452 | 955 | 447 |
| 30 Sep 22 | 3,525 | 502 | 916 | 429 |
| 30 Jun 22 | 3,460 | 552 | 877 | 412 |
| 31 Mar 22 | 3,418 | 577 | 846 | 399 |
| 31 Dec 21 | 3,376 | 601 | 816 | 386 |
| 30 Sep 21 | 3,296 | 555 | 801 | 381 |
| 30 Jun 21 | 3,216 | 509 | 786 | 377 |
| 31 Mar 21 | 3,167 | 457 | 788 | 388 |
| 31 Dec 20 | 3,118 | 404 | 789 | 399 |
| 30 Sep 20 | 2,997 | 355 | 784 | 399 |
| 30 Jun 20 | 2,876 | 305 | 778 | 398 |
| 31 Mar 20 | 2,775 | 289 | 764 | 386 |
| 31 Dec 19 | 2,675 | 273 | 750 | 374 |
| 30 Sep 19 | 2,601 | 268 | 721 | 362 |
| 30 Jun 19 | 2,527 | 263 | 693 | 350 |
| 31 Mar 19 | 2,474 | 260 | 668 | 338 |
| 31 Dec 18 | 2,421 | 257 | 643 | 327 |
| 30 Sep 18 | 2,372 | 264 | 626 | 320 |
| 30 Jun 18 | 2,323 | 271 | 609 | 312 |
| 31 Mar 18 | 2,306 | 255 | 607 | 308 |
| 31 Dec 17 | 2,288 | 238 | 604 | 304 |
| 30 Sep 17 | 2,262 | 216 | 604 | 300 |
| 30 Jun 17 | 2,237 | 195 | 604 | 295 |
| 31 Mar 17 | 2,170 | 187 | 587 | 283 |
| 31 Dec 16 | 2,103 | 179 | 570 | 272 |
| 30 Sep 16 | 2,068 | 158 | 555 | 260 |
| 30 Jun 16 | 2,032 | 137 | 540 | 249 |
| 31 Mar 16 | 1,998 | 124 | 534 | 244 |
| 31 Dec 15 | 1,965 | 111 | 529 | 239 |
| 30 Sep 15 | 1,908 | 127 | 510 | 230 |
| 30 Jun 15 | 1,851 | 144 | 492 | 222 |
| 31 Mar 15 | 1,775 | 140 | 472 | 214 |
| 31 Dec 14 | 1,698 | 135 | 453 | 206 |
| 30 Sep 14 | 1,656 | 135 | 437 | 201 |
| 30 Jun 14 | 1,614 | 135 | 422 | 196 |
| 31 Mar 14 | 1,601 | 150 | 413 | 191 |
| 31 Dec 13 | 1,588 | 164 | 405 | 186 |
Qualität der Erträge: BIM hat hohe Qualitätseinkünfte.
Wachsende Gewinnspanne: BIMDie aktuellen Gewinnspannen (10.8%) sind höher als im letzten Jahr (10.4%).
Analyse von freiem Cashflow und Gewinn
Analyse des Gewinnwachstums in der Vergangenheit
Ergebnisentwicklung: BIMIn den letzten 5 Jahren sind die Gewinne von 6.3% jährlich gestiegen.
Beschleunigtes Wachstum: BIMDas Gewinnwachstum des Unternehmens im letzten Jahr (6.6%) übertrifft seinen 5-Jahres-Durchschnitt (6.3% pro Jahr).
Erträge im Vergleich zur Industrie: BIM Das Gewinnwachstum im vergangenen Jahr (6.6%) übertraf nicht die Entwicklung der Branche Medical Equipment 12.7% .
Eigenkapitalrendite
Hohe Eigenkapitalrendite: BIMDie Eigenkapitalrendite des Unternehmens (10.3%) wird als niedrig angesehen.